Drug Type Bispecific antibody |
Synonyms- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Leyden Laboratories B.V.Startup |
Active Organization Leyden Laboratories B.V.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Virus Diseases | Discovery | - | Leyden Laboratories B.V.Startup | 12 Dec 2024 |